Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-23-007511
Filing Date
2023-05-01
Accepted
2023-05-01 16:54:55
Documents
14
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A omer-20221231x10ka.htm   iXBRL 10-K/A 954728
2 EX-31.3 omer-20221231xex31d3.htm EX-31.3 6225
3 EX-31.4 omer-20221231xex31d4.htm EX-31.4 6279
  Complete submission text file 0001558370-23-007511.txt   1221439

Data Files

Seq Description Document Type Size
4 EX-101.SCH omer-20221231.xsd EX-101.SCH 3228
5 EX-101.LAB omer-20221231_lab.xml EX-101.LAB 24152
6 EX-101.PRE omer-20221231_pre.xml EX-101.PRE 15127
8 EXTRACTED XBRL INSTANCE DOCUMENT omer-20221231x10ka_htm.xml XML 8094
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34475 | Film No.: 23874665
SIC: 2834 Pharmaceutical Preparations